Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04515901

Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches

Early Intervention Sphenopalatine Ganglion Blocks (SPGBs) Versus Standard Conservative Management of Post Dural Puncture Headache in Obstetric Patients - A Randomized Feasibility Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
McMaster University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Postdural puncture headache (PDPH) is a severe, debilitating complication of dural puncture that can arise from insertion of an epidural or spinal needle for labour analgesia. Presently, the conservative treatment options for PDPH have limited effectiveness and the gold standard treatment for PDPH, an epidural blood patch, is an invasive intervention with the potential for serious complications. There is a growing number of case reports and retrospective studies that suggest a sphenopalatine ganglion block (SPGB) with local anesthetic may offer an effective, safe, and easy-to-administer treatment option for PDPH in postpartum patients. We aim to conduct a feasibility study to assess whether a randomized controlled trial is feasible comparing whether early intervention SPGB with the option for repeat, patient self-administered SPGBs versus current standard conservative management can reduce the severity and duration of PDPH pain and improve patient functional status.

Conditions

Interventions

TypeNameDescription
DRUG2% lidocaineViscous lidocaine
OTHERPlaceboMethylcellulose and cherry flavouring

Timeline

Start date
2021-12-01
Primary completion
2022-11-11
Completion
2022-11-11
First posted
2020-08-17
Last updated
2022-12-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04515901. Inclusion in this directory is not an endorsement.